Sign in
CompletedNo phase

Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension

Key facts

Who runs it
Cairo University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
80 people enrolled
Started
22 Jun 2025
Ended
17 Sept 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction
Record updated
18 September 2025

Who can take part

Age
20 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adult patients with sepsis undergoing source control surgery

Who cannot take part

  • Patient with cardiac pathology ( ischemic heart disease or heart failure)
  • Patient refusal
  • Preoperative hemodynamic instability (defined as MAP < 65 mmHg)
  • Rapid sequence induction

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

researchers aim to evaluate the influence of prophylactic noradrenaline infusion on post-induction hypotension

The 2 groups in the trial

  • NoradrenalineExisting treatment, for comparison

    Noradrenaline will be infused at a fixed rate of 0.2 mic/kg/min at 5 minutes before induction

    Treatment: Noradrenaline 0.2 mcg/kg/min at 5 minutes before induction

  • ControlNo study treatment, for comparison

    Patients will receive normal saline

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Novel Use of Prophylactic Noradrenaline Infusion and Its Impact on Post-induction Hypotension in Patients With Surgical Sepsis, a Double Blind Randomized Controlled Trial
Publications
Record updated
18 September 2025